Answers are grounded in this paper and cite their sources.
Cost is a barrier to susceptibility testing being undertaken in most cases. Removal of the cost barrier and provision of a decision support tool resulted in positive changes to reported antimicrobial prescribing behaviour.
No takes yet. Share an insight, caveat, or question.
Hii et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: